| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 145.28B | 140.45B | 128.03B | 113.09B | 116.91B | 117.17B |
| Gross Profit | 25.63B | 24.75B | 20.70B | 16.01B | 21.17B | 23.16B |
| EBITDA | 5.77B | 13.22B | 8.56B | 8.27B | 23.71B | 12.02B |
| Net Income | 17.00M | 5.82B | 3.50B | 3.58B | 14.27B | 6.77B |
Balance Sheet | ||||||
| Total Assets | 180.43B | 187.75B | 170.42B | 158.16B | 154.35B | 142.74B |
| Cash, Cash Equivalents and Short-Term Investments | 16.89B | 20.29B | 19.44B | 33.63B | 37.31B | 21.90B |
| Total Debt | 29.88B | 30.18B | 11.94B | 11.17B | 1.33B | 1.16B |
| Total Liabilities | 72.10B | 70.47B | 52.72B | 46.19B | 41.34B | 42.15B |
| Stockholders Equity | 107.24B | 116.11B | 117.04B | 111.54B | 112.69B | 100.28B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.65B | -12.66B | -14.84B | 1.23B | 4.91B |
| Operating Cash Flow | 0.00 | 5.22B | -1.84B | -3.42B | 6.87B | 8.26B |
| Investing Cash Flow | 0.00 | -15.07B | -9.41B | -6.82B | 10.66B | -4.30B |
| Financing Cash Flow | 0.00 | 10.79B | -1.56B | 5.12B | -1.55B | -2.77B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥310.44B | 12.67 | ― | 2.99% | 0.31% | -11.04% | |
70 Outperform | ¥176.85B | 6.43 | 9.45% | 2.86% | 10.49% | -5.19% | |
70 Outperform | ¥86.06B | 15.03 | ― | 4.79% | 1.68% | 18.85% | |
67 Neutral | ¥110.87B | 13.75 | ― | 5.07% | 13.71% | -77.02% | |
67 Neutral | ¥1.16T | 13.34 | 9.16% | 3.98% | -2.72% | 29.43% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
51 Neutral | ¥16.76B | 0.51 | ― | 5.40% | -2.22% | 18.80% |